CHAMBON PHILIPPE

10% owner at WORLD HEART CORP · on record since Aug 8, 2008
Director at NxStage Medical, Inc. · on record since May 31, 2006
10% owner at NxStage Medical, Inc. · on record since May 31, 2006
Director at AUXILIUM PHARMACEUTICALS INC · on record since Jun 8, 2006
10% owner at AUXILIUM PHARMACEUTICALS INC · on record since Jun 8, 2006
10% owner at Paratek Pharmaceuticals, Inc. · on record since Feb 6, 2009
10% owner at Oxford Immunotec Global PLC · on record since Nov 21, 2013
Former 10% beneficial owner at Relypsa Inc · on record since Nov 20, 2013
Director at EPOCRATES INC · on record since Feb 7, 2011
10% owner at EPOCRATES INC · on record since Feb 7, 2011
Member of 10% owner group at ICAGEN INC · on record since Jul 29, 2011
Former 10% Beneficial Owner at Paratek Pharmaceuticals, Inc. · on record since Jul 20, 2011
10% owner at Relypsa Inc · on record since Nov 14, 2013
10% owner at Durata Therapeutics, Inc. · on record since Jul 26, 2012
10% owner at Lite Strategy, Inc. · on record since Dec 28, 2012
Director at Oruka Therapeutics, Inc. · on record since Dec 5, 2003
10% owner at iRhythm Holdings, Inc. · on record since Oct 25, 2016
Former 10% Beneficial Owner at Oxford Immunotec Global PLC · on record since Dec 3, 2013
10% owner at · on record since Mar 28, 2014
10% owner at · on record since Feb 21, 2014
10% owner at · on record since Mar 20, 2014

Insider trading activity of CHAMBON PHILIPPE

Transactions on record: 152; since Dec 5, 2003

Open-market buys: 7; $14.1M

Open-market sells: 25; $44.9M

Companies traded: 7; last filing Nov 18, 2014

Figures computed from official regulatory filings — .

Companies where CHAMBON PHILIPPE has traded

4 tx · $7.1M · Nov 18, 2014
1 tx · $251.4K · Oct 1, 2014
90 tx · $122.5M · Apr 2, 2013
12 tx · $9.4M · Mar 14, 2013
2 tx · $1M · Jul 15, 2011
41 tx · $35.1M · May 25, 2011
2 tx · May 10, 2004

Track record of CHAMBON PHILIPPE

Open-market buys: 7

Last buy: Jul 24, 2012

Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.

Transaction history of CHAMBON PHILIPPE

Co-insiders of CHAMBON PHILIPPE

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Durata Therapeutics, Inc.Listing unverified	Nov 18, 2014	Other	-3,028,439	—	—	SEC
Aravive, Inc.Listing unverified	Oct 1, 2014	Sell	-12,556	20.02 USD	$251.4K	SEC
NxStage Medical, Inc.Listing unverified	Apr 2, 2013	Award	1,041	0.00 USD	—	SEC
EPOCRATES INCListing unverified	Mar 14, 2013	OtherD (derivative)	-11,790	—	—	SEC
EPOCRATES INCListing unverified	Mar 14, 2013	Other	-2,644,170	—	—	SEC
EPOCRATES INCListing unverified	Mar 14, 2013	OtherD (derivative)	-15,720	—	—	SEC
EPOCRATES INCListing unverified	Mar 14, 2013	OtherD (derivative)	-11,790	—	—	SEC
EPOCRATES INCListing unverified	Mar 14, 2013	OtherD (derivative)	-15,720	—	—	SEC
NxStage Medical, Inc.Listing unverified	Jan 3, 2013	Award	1,044	0.00 USD	—	SEC
NxStage Medical, Inc.Listing unverified	Oct 2, 2012	Award	907	0.00 USD	—	SEC
EPOCRATES INCListing unverified	Aug 15, 2012	AwardD (derivative)	11,790	0.00 USD	—	SEC
Durata Therapeutics, Inc.Listing unverified	Jul 26, 2012	Other	2,244,126	—	—	SEC
Durata Therapeutics, Inc.Listing unverified	Jul 26, 2012	OtherD (derivative)	-17,953,008	0.00 USD	—	SEC
Durata Therapeutics, Inc.Listing unverified	Jul 26, 2012	Buy	784,313	9.00 USD	$7.1M	SEC
NxStage Medical, Inc.Listing unverified	Jul 3, 2012	Award	1,101	0.00 USD	—	SEC
NxStage Medical, Inc.Listing unverified	May 31, 2012	ExerciseD (derivative)	-2,442	0.00 USD	—	SEC
NxStage Medical, Inc.Listing unverified	May 31, 2012	Exercise	2,442	12.20 USD	$29.8K	SEC
NxStage Medical, Inc.Listing unverified	May 25, 2012	AwardD (derivative)	15,272	0.00 USD	—	SEC
NxStage Medical, Inc.Listing unverified	Apr 3, 2012	Award	635	0.00 USD	—	SEC
NxStage Medical, Inc.Listing unverified	Mar 20, 2012	Sell	-74,401	19.28 USD	$1.4M	SEC
NxStage Medical, Inc.Listing unverified	Mar 7, 2012	Sell	-22,473	18.94 USD	$425.6K	SEC
NxStage Medical, Inc.Listing unverified	Jan 11, 2012	Other	-863,676	17.86 USD	$15.4M	SEC
NxStage Medical, Inc.Listing unverified	Jan 3, 2012	Award	773	0.00 USD	—	SEC
NxStage Medical, Inc.Listing unverified	Oct 4, 2011	Award	491	0.00 USD	—	SEC
NxStage Medical, Inc.Listing unverified	Sep 16, 2011	Sell	-20,110	18.58 USD	$373.6K	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Durata Therapeutics, Inc.Listing unverified	Nov 18, 2014	Other	-3,028,439	—	—	SEC
Aravive, Inc.Listing unverified	Oct 1, 2014	Sell	-12,556	20.02 USD	$251.4K	SEC
NxStage Medical, Inc.Listing unverified	Apr 2, 2013	Award	1,041	0.00 USD	—	SEC
EPOCRATES INCListing unverified	Mar 14, 2013	OtherD (derivative)	-11,790	—	—	SEC
EPOCRATES INCListing unverified	Mar 14, 2013	Other	-2,644,170	—	—	SEC
EPOCRATES INCListing unverified	Mar 14, 2013	OtherD (derivative)	-15,720	—	—	SEC
EPOCRATES INCListing unverified	Mar 14, 2013	OtherD (derivative)	-11,790	—	—	SEC
EPOCRATES INCListing unverified	Mar 14, 2013	OtherD (derivative)	-15,720	—	—	SEC
NxStage Medical, Inc.Listing unverified	Jan 3, 2013	Award	1,044	0.00 USD	—	SEC
NxStage Medical, Inc.Listing unverified	Oct 2, 2012	Award	907	0.00 USD	—	SEC
EPOCRATES INCListing unverified	Aug 15, 2012	AwardD (derivative)	11,790	0.00 USD	—	SEC
Durata Therapeutics, Inc.Listing unverified	Jul 26, 2012	Other	2,244,126	—	—	SEC
Durata Therapeutics, Inc.Listing unverified	Jul 26, 2012	OtherD (derivative)	-17,953,008	0.00 USD	—	SEC
Durata Therapeutics, Inc.Listing unverified	Jul 26, 2012	Buy	784,313	9.00 USD	$7.1M	SEC
NxStage Medical, Inc.Listing unverified	Jul 3, 2012	Award	1,101	0.00 USD	—	SEC
NxStage Medical, Inc.Listing unverified	May 31, 2012	ExerciseD (derivative)	-2,442	0.00 USD	—	SEC
NxStage Medical, Inc.Listing unverified	May 31, 2012	Exercise	2,442	12.20 USD	$29.8K	SEC
NxStage Medical, Inc.Listing unverified	May 25, 2012	AwardD (derivative)	15,272	0.00 USD	—	SEC
NxStage Medical, Inc.Listing unverified	Apr 3, 2012	Award	635	0.00 USD	—	SEC
NxStage Medical, Inc.Listing unverified	Mar 20, 2012	Sell	-74,401	19.28 USD	$1.4M	SEC
NxStage Medical, Inc.Listing unverified	Mar 7, 2012	Sell	-22,473	18.94 USD	$425.6K	SEC
NxStage Medical, Inc.Listing unverified	Jan 11, 2012	Other	-863,676	17.86 USD	$15.4M	SEC
NxStage Medical, Inc.Listing unverified	Jan 3, 2012	Award	773	0.00 USD	—	SEC
NxStage Medical, Inc.Listing unverified	Oct 4, 2011	Award	491	0.00 USD	—	SEC
NxStage Medical, Inc.Listing unverified	Sep 16, 2011	Sell	-20,110	18.58 USD	$373.6K	SEC